Clinical Trial Update: Phase II/III of Recombinant Human Serum Albumin [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III clinical trial evaluating recombinant human serum albumin for cirrhotic ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Recombinant Human Serum Albumin (recombinant human serum albumin)

Snippet

Sponsor: Protgen Ltd | Conditions: Cirrhotic Ascites | Phase 2, Phase 3 | Status: COMPLETED